Drug & medication recalls Moderate risk

Ibuprofen Caplets USP 200 mg recalled over manufacturing violations

Recall date
January 11, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Time-Cap Laboratories, Inc. recalls Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 49483-600-05), b) 100 caplets (NDC 49483-600-01), c) 500 caplets (NDC…
Recall number
D-0694-2018
FDA classification
Class II
Brand / firm
Time-Cap Laboratories, Inc.
Sold / distributed
Nationwide.

Why it was recalled

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 49483-600-05), b) 100 caplets (NDC 49483-600-01), c) 500 caplets (NDC 49483-600-50), and d) BULK (NDC 49483-600-00) bottles, Rx, Manufactured for: Time Cap labs, Inc., Farmingdale, NY 11735, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

Get recall alerts

Free email alert whenever Time-Cap Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Time-Cap Laboratories, Inc.